ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dysport® Adult Upper Limb Spasticity Extension Study

ClinicalTrials.gov ID: NCT01313312

Public ClinicalTrials.gov record NCT01313312. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicentre, Prospective, Open Label Extension Study to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury

Study identification

NCT ID
NCT01313312
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ipsen
Industry
Enrollment
258 participants

Conditions and interventions

Interventions

  • Botulinum toxin type A Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Nov 30, 2014
Completion
Nov 30, 2014
Last update posted
Sep 27, 2022

2011 – 2014

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Rancho Los Amigos National Rehabilitation Center Downey California 90242
Associated Neurologist of Southern CT, PT Fairfield Connecticut 06824
Parkinson's Disease & Movement Disorders Center of Boca Raton Boca Raton Florida 33488
Design Neuroscience Miami South Miami Florida 33143
The Rehabilitation Institute of Chicago Chicago Illinois 60611
Mount Sinai School of Medicine New York New York 10029-6574
Weill Cornell Medical College New York New York 10065
Univ of North Carolina - Chapel Hill Chapel Hill North Carolina 27599
Wake Forest Medical Center Winston-Salem North Carolina 27157
Vanderbilt University Nashville Tennessee 37232
Southwestern Medical Center at Dallas University of Texas Dallas Texas 75390
University of North Texas HSC at Ben Hogan Center Fort Worth Texas 76104
University of Utah School of Medicine Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01313312, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01313312 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →